Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Recent Targets in Drug Discovery: A Review


Affiliations
1 Siddhi Vinayaka Institute of Technical Sciences, Mangla, Bilaspur, Chhattisgarh, India
2 Institute of Pharmacy, RITEE, Chhatauna, Mandir Hasaud, Raipur, Chhattisgarh, India
3 School of Pharmaceutical Sciences, Siksha O Anushandhan University, Bhubneshwar, Orissa, India
     

   Subscribe/Renew Journal


Drug design and drug discovery have critical importance in human health care. There are various sites for the drug targeting like cell membrane, intracellular constituents, outside the cell and possibly antimicrobial action. Receptor as agonist and antagonist, enzymes and pumps, ion channels, physicochemical action with Lipid, protein or water constituents of nerve cell membrane are targeted on cell membrane. Various type of nuclear receptor like Oestrogen, retinoid, vitamin-D, Glucocorticoid, Thyroid hormone, peroxisome proliferators, liver receptor etc. are targeted on the intracellular constituents. The traditional approach of drug discovery involves target identification, validation, lead search and optimization followed by clinical development phases. The recent targets for drug action are DNA, Nuclear Receptors e.g. Retinoid Receptors, Ion Channels e.g. Calcium channel, Enzymes e.g. Cholinesterase, Receptors e.g. Adenosine Receptor in the present work different targets of drug action are discussed in brief which is an essential part during discovery phase of a drug.

Keywords

Drug Design, Drug Discovery, Receptors, Targets.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Osman F. Guner Pharmacophore Perception, Development, and use in Drug Design. An essential tool for organic chemist. 2000; 3: 48-53.

  • Thierry L and Remy D. Hoffmann. Pharmacophores and Pharmacophore Searches. Pharmacophores and Pharmacophore Searches. 2006; 2: 29-35.

  • Bruce A, Johnson A, Julian L, Martin R, Roberts K and Peter W. Molecular Biology of the Cell. New York and London, Garland Science. 2000.

  • Butler John M. Forensic DNA Typing. Elsevier. 2001. pp. 4-15.

  • Mandelkern M, Elias J, Eden D and Crothers D. The dimensions of DNA in solution. J Mol Biol. 1981; 152: 153-161.

  • Gregory S. The DNA sequence and biological annotation of human chromosome 1. Nature. 2006; 441: 315-321.

  • Watson J and Crick F. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953; 171: 737-738.

  • Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988; 240: 889-895.

  • Garrett RH and Grisham CM. Biochemistry. Second Edition Saunders College Publishing. 1999; pp. 426-427.

  • Bairoch A. The ENZYME database in 2000. Nucleic Acids Res. 2000; 28: 304-305.

  • Lilley D. Structure, folding and mechanisms of ribozymes. Curr Opin Struct Biol 2005; 15: 313-323.

  • De Reaumur R. Observations sur la digestion des oiseaux. Histoire de l'academie royale des sciences. 1752; 266: 461-462.

  • Williams HS. A History of Science: Development of the Chemical and Biological Sciences. Harper and Brothers New York. 2007.

  • Dubos J. Louis Pasteur: Free Lance of Science. Trends Biotechnol. 1995; 13: 511-515.

  • Nobel Laureate Biography of Eduard Buchner at http://nobelprize.org. Accessed 04 April 2007.

  • George JS, Bernard W, Agranoff R, Albers W, Stephen KF and Michael D. Neurochemistry: Molecular, Cellular, and Medical Aspects. Williams & Wilkins Lippincott. 1999.

  • Bertil H. Ion channels of excitable membranes. Sinauer Associates, Sunderland, 2001.

  • Walter F. Medical Physiology: A Cellular And Molecular Approach Elsevier/Saunders. 2005. pp.479.

  • Suzuki M, Morita T and Iwamoto T. Diversity of Cl(-) channels. Cell Mol Life Sci. 2006; 63: 12-24.

  • Jessell TM, Kandel ER and Schwartz JH.. Principles of Neural Science, 4th ed., New York: McGraw-Hill. 2000. pp.154-169.

  • Bertil H. Ion Channels of Excitable Membranes. Sunderland, Mass: Sinauer. 2001. pp. 73-77.

  • Yu FH and Catterall WA. Overview of the voltage-gated sodium channel family. Genome Biol. 2003; 4: 207-208.

  • Beato M, Chavez S and Truss M. Transcriptional regulation by steroid hormones. Steroids. 1996; 61: 240-251.

  • Hammes SR. The further redefining of steroid-mediated signaling. Proc Natl Acad Sci. 2003; 100: 2168-2170.

  • Kosfeld M. Oxytocin increases trust in humans. Nature 2005; 435: 673-676.

  • Scientific American Mind, Rhythm and Blues; June/July 2007; Scientific American Mind; by Ulrich Kraft. 2007.

  • Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006; 354: 2034-2045.

  • Massaro D and Massaro GD. Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice. American Journal of Physiology, Lung Cellular and Molecular Physiology. 2004; 287: 1154-1159.


Abstract Views: 222

PDF Views: 2




  • Recent Targets in Drug Discovery: A Review

Abstract Views: 222  |  PDF Views: 2

Authors

Shweta Paroha
Siddhi Vinayaka Institute of Technical Sciences, Mangla, Bilaspur, Chhattisgarh, India
Ravindra Dhar Dubey
Institute of Pharmacy, RITEE, Chhatauna, Mandir Hasaud, Raipur, Chhattisgarh, India
Subrata Mallick
School of Pharmaceutical Sciences, Siksha O Anushandhan University, Bhubneshwar, Orissa, India

Abstract


Drug design and drug discovery have critical importance in human health care. There are various sites for the drug targeting like cell membrane, intracellular constituents, outside the cell and possibly antimicrobial action. Receptor as agonist and antagonist, enzymes and pumps, ion channels, physicochemical action with Lipid, protein or water constituents of nerve cell membrane are targeted on cell membrane. Various type of nuclear receptor like Oestrogen, retinoid, vitamin-D, Glucocorticoid, Thyroid hormone, peroxisome proliferators, liver receptor etc. are targeted on the intracellular constituents. The traditional approach of drug discovery involves target identification, validation, lead search and optimization followed by clinical development phases. The recent targets for drug action are DNA, Nuclear Receptors e.g. Retinoid Receptors, Ion Channels e.g. Calcium channel, Enzymes e.g. Cholinesterase, Receptors e.g. Adenosine Receptor in the present work different targets of drug action are discussed in brief which is an essential part during discovery phase of a drug.

Keywords


Drug Design, Drug Discovery, Receptors, Targets.

References